The possible role of interleukin (IL)-12 and interferon-γ-inducing factor/IL-18 in protection against experimental Mycobacterium leprae infection in mice

Clinical Immunology and Immunopathology

Volumn 88, Issue 3, 1998, Pages 226-231

  Kobayashi, Kazuo ^a   Kai, Masanori ^a   Gidoh, Masa ichi ^a   Nakata, Noboru ^a   Endoh, Masumi ^a   Singh, Ram Pyare ^a   Kasama, Tsuyoshi ^b   Saito, Hajime ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^b SHOWA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Interferon inducing factor; Interleukin 12; Mycobacterial infections; Protection

Indexed keywords

BETA ACTIN; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 12; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; FEMALE; GENE EXPRESSION; HELPER CELL; HISTOPATHOLOGY; HOST RESISTANCE; LEPROSY; MACROPHAGE; MOUSE; MYCOBACTERIUM LEPRAE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE ACTIVATION; TREATMENT OUTCOME;

EID: 0032169916     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1998.4533     Document Type: Article

References (36)

1. Kaufmann S. H. E. Immunity to intracellular microbial pathogens. Immunol. Today. 16:1995;338-343.
2. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:1995;251-276.
3. Okamura H., Tsutsui H., Komatsu T., Yutsudo M., Kakura A., Tanimoto T., Torigoe K., Okura T., Nukada Y., Hattori K., Akita K., Namba M., Tanabe F., Konishi K., Fukuda S., Kurimoto M. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature. 378:1995;88-91.
4. Staats J. Standardized nomenclature for inbred strains of mice. Cancer Res. 40:1980;2083-2128.
5. Mori T., Miyata Y., Kohsaka K., Makino M. Respiration inMycobacterium leprae. Int. J. Lepr. 53:1985;600-609.
6. Shepard C. C., McRae D. H. A method for counting acid-fast bacteria. Int. J. Lepr. 36:1968;78-82.
7. Kobayashi K., Yamazaki J., Kasama T., Katsura T., Kasahara K., Wolf S. F., Shimamura T. Interleukin (IL)-12 deficiency in susceptible mice infected withMycobacterium avium. J. Infect. Dis. 174:1996;564-573.
8. Gray P. W., Glaister D., Chen E., Goeddel D. V., Pennica D. Two interleukin 1 genes in the mouse. Cloning and expression of the cDNA for murine interleukin 1β J. Immunol. 137:1986;3644-3648.
9. Pennica D., Hayflick J. S., Bringman T. S., Palladino M. A., Goeddel D. V. Cloning and expression inEscherichia coli. Proc. Natl. Acad. Sci. USA. 82:1985;6060-6064.
10. Davatelis G., Tekamp-Olson P., Wolpe S. D., Hermsen K., Luedke C., Gallegos C., Coit D., Merryweather J., Cerami A. Cloning and characterization of a cDNA for murine macrophage inflammatory protein (MIP), a novel monokine with inflammatory and chemokinetic properties. J. Exp. Med. 167:1988;1939-1944.
11. James S. P. Detection of cytokine mRNA expression by PCR. Current Protocols in Immunology. 1994;Wiley, New York. p. 10-23-1-10-23-10.
12. Kobayashi K., Kasama T., Yamazaki J., Hosaka M., Katsura T., Mochizuki T., Soejima K., Nakamura R. M. Protection of mice fromMycobacterium avium. Antimicrob. Agents Chemother. 39:1995;1369-1371.
13. Trinchieri G., Scott P. The role of interleukin 12 in the immune response, disease and therapy. Immunol. Today. 15:1994;460-463.
14. Sato I. Y., Kobayashi K., Kasama T., Kaga S., Kasahara K., Kanemitsu H., Nakatani K., Takahashi T., Nakamura R. M., Skamene E., Yoshida T. Regulation ofMycobacterium bovisBcg. Infect. Immun. 58:1990;1210-1216.
15. Kobayashi K., Yoshida T. The immunopathogenesis of granulomatous inflammation induced byMycobacterium tuberculosis. Methods. 9:1996;204-214.
16. Kasahara K., Kobayashi K., Shikama Y., Yoneya I., Kaga S., Hashimoto M., Odagiri T., Soejima K., Ide H., Takahashi T., Yoshida T. The role of monokines in granuloma formation in mice: the ability of interleukin-1 and tumor necrosis factor-α to induce lung granulomas. Clin. Immunol. Immunopathol. 51:1989;419-425.
17. Kasahara K., Tobe T., Tomita M., Mukaida N., Shao-Bu S., Matsushima K., Yoshida T., Sugihara S., Kobayashi K. Selective expression of monocyte chemotactic and activating factor/monocyte chemoattractant protein 1 in human blood monocytes byMycobacterium tuberculosis. J. Infect. Dis. 170:1994;1238-1247.
18. Lin R., Tarr P. E., Jones T. C. Present status of the use of cytokines as adjuvants with vaccines to protect against infectious diseases. Clin. Infect. Dis. 21:1995;1439-1449.
19. Kobayashi K., Allred C., Castriotta R., Yoshida T. Strain variation ofBacillus Calmette-Guerin. Am. J. Pathol. 119:1985;223-235.
20. Bermudez L. E., Kaplan G. Recombinant cytokines for controlling mycobacterial infections. Trends Microbiol. 3:1995;22-27.
21. Nathan C. F., Kaplan G., Levis W. R., Nusrat A., Witmer M. D., Sherwin S. A., Job C. K., Horowitz C. R., Steinman R. M., Cohn Z. A. Local and systemic effects of intradermal recombinant interferon-γ in patients with lepromatous leprosy. N. Engl. J. Med. 315:1986;6-15.
22. Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile J.-F., Newport M., Levin M., Blanche S., Seboun E., Fischer A., Casanova J.-L. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N. Engl. J. Med. 335:1996;1956-1961.
23. Newport M. J., Huxley C. M., Huston S., Hawrylowicz C. M., Oostra B. A., Williamson R., Levin M. A mutation in the interferon-γ-receptor gene and susceptibility to mycobacterial infection. N. Engl. J. Med. 335:1996;1941-1949.
24. Wang Z.-E., Zheng S., Corry D. B., Dalton D. K., Seder R. A., Reiner S. L., Locksley R. M. Interferon γ-independent effects of interleukin 12 administered during acute or established infection due toLeishmania major. Proc. Natl. Acad. Sci. USA. 91:1994;12932-12936.
25. Taylor A. P., Murray H. W. Intracellular antimicrobial activity in the absence of interferon-γ: effect of interleukin-12 in experimental visceral leishmaniasis in interferon-γ gene-disrupted mice. J. Exp. Med. 185:1997;1231-1239.
26. Perry L. L., Feilzer K., Caldwell H. D. Immunity toChlamydia trachomatis. J. Immunol. 158:1997;3344-3352.
27. Komatsu T., Reiss C. S. IFN-γ is not required in the IL-12 response to vesicular stomatitis virus infection of the olfactory bulb. J. Immunol. 159:1997;3444-3452.
28. Trinchieri G. Interleukin-12 and interferon-γ: do they always go together. Am. J. Pathol. 147:1995;1534-1538.
29. Heinzel F. P., Rerko R. M., Ahmed F., Hujer A. M. IFN-γ-independent production of IL-12 during murine endotoxemia. J. Immunol. 157:1996;4521-4528.
30. Romani L., Puccetti P., Bistoni F. Interleukin-12 in infectious diseases. Clin. Microbiol. Rev. 10:1997;611-636.
31. Flesch I. E. A., Hess J. H., Huang S., Aguet M., Rothe J., Bluethmann H., Kaufmann S. H. E. Early interleukin 12 production by macrophages in response to mycobacterial antigen depends on interferon γ and tumor necrosis factor α J. Exp. Med. 181:1995;1615-1621.
32. Castro A. G., Silva R. A., Appelberg R. Endogenously produced IL-12 is required for the induction of protective T cells duringMycobacterium avium. J. Immunol. 155:1995;2013-2019.
33. Cooper A. M., Magram J., Ferrante J., Orme I. M. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected withMycobacterium tuberculosis. J. Exp. Med. 186:1997;39-45.
34. Frucht D. M., Holland S. M. Defective monocyte costimulation for IFN-γ production in familial disseminatedMycobacterium avium. J. Immunol. 157:1996;411-416.
35. Romagnani S. The Th1/Th2 paradigm. Immunol. Today. 157:1996;411-416.
36. Yamamura M., Uyemura K., Deans R. J., Weinberg K., Rea T. H., Bloom B. R., Modlin R. L. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science. 254:1991;277-279.